Ross Donehower
Senior Advisor · Johns Hopkins University School of Medicine
Credentials: · · · · ·
History
- 1977–1979
Medical Oncology
- 1974–1977
Internal Medicine
Research
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine · 2015 · 7,710 citations
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Science · 2017 · 5,443 citations
Review · New England Journal of Medicine · 1995 · 1,804 citations
- LG
51 papers
- ER
44 papers
37 papers · 1 as a fellow
- DE
29 papers
20 papers · 14 as a fellow
- DL
15 papers
14 papers
14 papers · 1 as a fellow
Grants
- 1992–2009
Clinical Oncology Research Career Development Program
National Cancer Institute · K12
Contact PI · $3.6M · Johns Hopkins University
- 1995–2003
Phase I Clinical Trials of New Anti-Cancer Targeted Therapies
National Cancer Institute · U01
Contact PI · $2.5M · Johns Hopkins University
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $117.5K · Johns Hopkins University
- 1994–1999
Phase Ii Trials of New Anticancer Agents
National Cancer Institute · U01
Contact PI · $1.6M · Johns Hopkins University
Clinical trials
- 2002
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2001
DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
Study chair · Unknown · Phase 2
Theradex
- 2001
DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
Study chair · Unknown · Phase 2
Theradex
- 1999–2008
MG98 in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
NCIC Clinical Trials Group